Publicaciones en colaboración con investigadores/as de University of Melbourne (1)

2022

  1. Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONE

    Blood, Vol. 139, Núm. 4, pp. 492-501